Log in to save to my catalogue

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2657315386

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

About this item

Full title

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-04, Vol.17 (4), p.e0267504-e0267504

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining real-world outcomes is essential to evaluate the cost-effectiveness of different therapeutic strategies. This study aimed to investigate the variability in the annual cost of DMTs associated with a...

Alternative Titles

Full title

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2657315386

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2657315386

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0267504

How to access this item